홈케어 임상 영양 시장 규모, 점유율, 성장 및 세계 업계 분석 : 유형 및 용도별, 지역별 인사이트 및 예측(2026-2034년)

Growth Factors of homecare clinical nutrition Market

The global homecare clinical nutrition market was valued at USD 22.13 billion in 2025 and is projected to grow to USD 23.10 billion in 2026, reaching USD 35.80 billion by 2034, exhibiting a CAGR of 5.63% during the forecast period. North America dominated the market with a 34.44% share in 2025, driven by strong healthcare infrastructure and widespread adoption of home-based clinical nutrition services.

Homecare clinical nutrition focuses on delivering nutritional support to patients suffering from chronic conditions such as cancer, cardiovascular diseases, and neurological disorders in home settings. Rising cases of malnutrition and chronic illnesses are significantly contributing to market expansion.

Market Dynamics

Drivers

The increasing prevalence of chronic diseases such as diabetes and cancer is a major growth driver. For instance, millions of people globally require long-term nutritional support due to disease-related complications like poor appetite and digestion issues. Additionally, the growing geriatric population is further accelerating demand, as elderly individuals are more prone to chronic illnesses.

Rising awareness about the importance of clinical nutrition, along with technological advancements in nutritional formulations, is also boosting market growth.

Restraints

Despite strong growth potential, limited reimbursement policies for clinical nutrition products in several countries restrict market expansion. High costs of specialized nutritional formulations and strict regulatory frameworks further pose challenges for manufacturers and patients alike.

Opportunities

Increasing investment in research and development, especially in emerging markets, is creating new opportunities. Companies are focusing on personalized and disease-specific nutrition solutions, improving treatment outcomes and patient convenience. The integration of digital health and telehealth services is also enhancing patient monitoring and accessibility.

Challenges

Intense competition among major players and the constant need for innovation remain key challenges. Additionally, limited raw material availability and high development costs may impact market growth.

Market Trends

A key trend shaping the market is the growing demand for disease-specific nutrition products. These products are designed to meet individual patient needs, improving recovery rates and nutritional outcomes. There is also rising interest in plant-based and functional nutrition products, along with increased use of telehealth platforms for remote patient care.

Segmentation Analysis

By Type

The services segment dominated the market with a 64.68% share in 2026, driven by increasing demand for nutrition counseling, meal planning, and feeding assistance at home. The products segment, including oral and enteral nutrition, is also growing steadily.

By Age Group

The adult segment held the largest share of 73.37% in 2026, due to the high prevalence of chronic diseases among adults. The pediatric segment is also expanding due to rising malnutrition cases.

By Form

The liquid segment dominated with a 65.57% share in 2026, owing to better digestibility and convenience. Powder-based products are gaining traction due to affordability.

By Therapeutic Area

The oncology segment led the market with a 38.37% share in 2026, driven by increasing cancer cases and associated malnutrition risks.

Regional Insights

• North America: Valued at USD 7.62 billion in 2025, growing to USD 7.95 billion in 2026, supported by strong home healthcare infrastructure.
• Europe: Reached USD 6.42 billion in 2025 and USD 6.70 billion in 2026, driven by rising healthcare expenditure.
• Asia Pacific: Accounted for USD 5.25 billion in 2025 and USD 5.49 billion in 2026, fueled by growing awareness and improving healthcare systems.
• Latin America & Middle East & Africa: Showing moderate growth due to increasing adoption of clinical nutrition services.

Competitive Landscape

Key players such as Nestle, Abbott, and Nutricia (Danone) dominate the market. These companies focus on product innovation, partnerships, and acquisitions to strengthen their market presence. Other notable players include Baxter and Fresenius Kabi AG.

Conclusion

The homecare clinical nutrition market is set for steady growth, increasing from USD 22.13 billion in 2025 to USD 35.80 billion by 2034. Rising chronic disease prevalence, aging populations, and growing demand for home-based healthcare are key growth drivers. Despite challenges such as reimbursement limitations and high costs, advancements in personalized nutrition and digital healthcare solutions will create significant opportunities. Overall, the market is expected to witness sustained expansion, supported by innovation and increasing global awareness of clinical nutrition.

Segmentation By Type

• Services
  • Nutrition Assessment
  • Meal Preparation & Delivery
  • Feeding Assistance
  • Others
• Products
  • Oral
  • Parenteral
  • Enteral Tube Feeding

By Age Group

• Pediatric
• Adult

By Form

• Powder
• Liquid

By Therapeutic Area

• Oncology
• Neurological Disorders
• Gastrointestinal Disorders
• Diabetes
• Kidney Disorders
• Cardiovascular Disorders
• Others

By Region

• North America (By Type, By Age Group, By Form, By Therapeutic Area, and By Country)
  • U.S.
  • Canada
• Europe (By Type, By Age Group, By Form, By Therapeutic Area, and By Country/Sub-region)
  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Poland
  • Switzerland
  • Rest of Europe
• Asia Pacific (By Type, By Age Group, By Form, By Therapeutic Area, and By Country/Sub-region)
  • China
  • Japan
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Type, By Age Group, By Form, By Therapeutic Area, and By Country/Sub-region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Type, By Age Group, By Form, By Therapeutic Area, and By Country/Sub-region)
  • GCC
  • South Africa
  • Rest of Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Key Chronic Diseases, Key Countries/Regions, 2025
• 4.2. New Product Launches, By Key Players
• 4.3. Key Industry Developments - Mergers, Acquisitions, Partnerships, etc.
• 4.4. Impact of COVID-19 on the Market

5. Global Homecare Clinical Nutrition Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Type
  • 5.1.1. Services
    • 5.1.1.1. Nutrition Assessment
    • 5.1.1.2. Meal Preparation & Delivery
    • 5.1.1.3. Feeding Assistance
    • 5.1.1.4. Others
  • 5.1.2. Products
    • 5.1.2.1. Oral
    • 5.1.2.2. Parenteral
    • 5.1.2.3. Enteral Tube Feeding
• 5.2. Market Analysis, Insights and Forecast - By Age Group
  • 5.2.1. Pediatric
  • 5.2.2. Adult
• 5.3. Market Analysis, Insights and Forecast - By Form
  • 5.3.1. Powder
  • 5.3.2. Liquid
• 5.4. Market Analysis, Insights and Forecast - By Therapeutic Area
  • 5.4.1. Oncology
  • 5.4.2. Neurological Disorders
  • 5.4.3. Gastrointestinal Disorders
  • 5.4.4. Diabetes
  • 5.4.5. Kidney Disorders
  • 5.4.6. Cardiovascular Disorders
  • 5.4.7. Others
• 5.5. Market Analysis, Insights and Forecast - By Region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa

6. North America Homecare Clinical Nutrition Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Type
  • 6.1.1. Services
    • 6.1.1.1. Nutrition Assessment
    • 6.1.1.2. Meal Preparation & Delivery
    • 6.1.1.3. Feeding Assistance
    • 6.1.1.4. Others
  • 6.1.2. Products
    • 6.1.2.1. Oral
    • 6.1.2.2. Parenteral
    • 6.1.2.3. Enteral Tube Feeding
• 6.2. Market Analysis, Insights and Forecast - By Age Group
  • 6.2.1. Pediatric
  • 6.2.2. Adult
• 6.3. Market Analysis, Insights and Forecast - By Form
  • 6.3.1. Powder
  • 6.3.2. Liquid
• 6.4. Market Analysis, Insights and Forecast - By Therapeutic Area
  • 6.4.1. Oncology
  • 6.4.2. Neurological Disorders
  • 6.4.3. Gastrointestinal Disorders
  • 6.4.4. Diabetes
  • 6.4.5. Kidney Disorders
  • 6.4.6. Cardiovascular Disorders
  • 6.4.7. Others
• 6.5. Market Analysis, Insights and Forecast - By Country
  • 6.5.1. U.S.
  • 6.5.2. Canada

7. Europe Homecare Clinical Nutrition Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Type
  • 7.1.1. Services
    • 7.1.1.1. Nutrition Assessment
    • 7.1.1.2. Meal Preparation & Delivery
    • 7.1.1.3. Feeding Assistance
    • 7.1.1.4. Others
  • 7.1.2. Products
    • 7.1.2.1. Oral
    • 7.1.2.2. Parenteral
    • 7.1.2.3. Enteral Tube Feeding
• 7.2. Market Analysis, Insights and Forecast - By Age Group
  • 7.2.1. Pediatric
  • 7.2.2. Adult
• 7.3. Market Analysis, Insights and Forecast - By Form
  • 7.3.1. Powder
  • 7.3.2. Liquid
• 7.4. Market Analysis, Insights and Forecast - By Therapeutic Area
  • 7.4.1. Oncology
  • 7.4.2. Neurological Disorders
  • 7.4.3. Gastrointestinal Disorders
  • 7.4.4. Diabetes
  • 7.4.5. Kidney Disorders
  • 7.4.6. Cardiovascular Disorders
  • 7.4.7. Others
• 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.5.1. U.K.
  • 7.5.2. Germany
  • 7.5.3. France
  • 7.5.4. Spain
  • 7.5.5. Italy
  • 7.5.6. Poland
  • 7.5.7. Switzerland
  • 7.5.8. Rest of Europe

8. Asia Pacific Homecare Clinical Nutrition Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Type
  • 8.1.1. Services
    • 8.1.1.1. Nutrition Assessment
    • 8.1.1.2. Meal Preparation & Delivery
    • 8.1.1.3. Feeding Assistance
    • 8.1.1.4. Others
  • 8.1.2. Products
    • 8.1.2.1. Oral
    • 8.1.2.2. Parenteral
    • 8.1.2.3. Enteral Tube Feeding
• 8.2. Market Analysis, Insights and Forecast - By Age Group
  • 8.2.1. Pediatric
  • 8.2.2. Adult
• 8.3. Market Analysis, Insights and Forecast - By Form
  • 8.3.1. Powder
  • 8.3.2. Liquid
• 8.4. Market Analysis, Insights and Forecast - By Therapeutic Area
  • 8.4.1. Oncology
  • 8.4.2. Neurological Disorders
  • 8.4.3. Gastrointestinal Disorders
  • 8.4.4. Diabetes
  • 8.4.5. Kidney Disorders
  • 8.4.6. Cardiovascular Disorders
  • 8.4.7. Others
• 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.5.1. Japan
  • 8.5.2. Australia
  • 8.5.3. China
  • 8.5.4. India
  • 8.5.5. Southeast Asia
  • 8.5.6. Rest of Asia Pacific

9. Latin America Homecare Clinical Nutrition Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Type
  • 9.1.1. Services
    • 9.1.1.1. Nutrition Assessment
    • 9.1.1.2. Meal Preparation & Delivery
    • 9.1.1.3. Feeding Assistance
    • 9.1.1.4. Others
  • 9.1.2. Products
    • 9.1.2.1. Oral
    • 9.1.2.2. Parenteral
    • 9.1.2.3. Enteral Tube Feeding
• 9.2. Market Analysis, Insights and Forecast - By Age Group
  • 9.2.1. Pediatric
  • 9.2.2. Adult
• 9.3. Market Analysis, Insights and Forecast - By Form
  • 9.3.1. Powder
  • 9.3.2. Liquid
• 9.4. Market Analysis, Insights and Forecast - By Therapeutic Area
  • 9.4.1. Oncology
  • 9.4.2. Neurological Disorders
  • 9.4.3. Gastrointestinal Disorders
  • 9.4.4. Diabetes
  • 9.4.5. Kidney Disorders
  • 9.4.6. Cardiovascular Disorders
  • 9.4.7. Others
• 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America

10. Middle East & Africa Homecare Clinical Nutrition Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Type
  • 10.1.1. Services
    • 10.1.1.1. Nutrition Assessment
    • 10.1.1.2. Meal Preparation & Delivery
    • 10.1.1.3. Feeding Assistance
    • 10.1.1.4. Others
  • 10.1.2. Products
    • 10.1.2.1. Oral
    • 10.1.2.2. Parenteral
    • 10.1.2.3. Enteral Tube Feeding
• 10.2. Market Analysis, Insights and Forecast - By Age Group
  • 10.2.1. Pediatric
  • 10.2.2. Adult
• 10.3. Market Analysis, Insights and Forecast - By Form
  • 10.3.1. Powder
  • 10.3.2. Liquid
• 10.4. Market Analysis, Insights and Forecast - By Therapeutic Area
  • 10.4.1. Oncology
  • 10.4.2. Neurological Disorders
  • 10.4.3. Gastrointestinal Disorders
  • 10.4.4. Diabetes
  • 10.4.5. Kidney Disorders
  • 10.4.6. Cardiovascular Disorders
  • 10.4.7. Others
• 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 10.5.1. GCC
  • 10.5.2. South Africa
  • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
  • 11.1.1. By Products
  • 11.1.2. By Services
• 11.2. Company Profiles
  • 11.2.1. Ajinomoto Co., Inc.
    • 11.2.1.1. Overview
    • 11.2.1.2. Products & services
    • 11.2.1.3. SWOT Analysis
    • 11.2.1.4. Recent Developments
    • 11.2.1.5. Strategies
    • 11.2.1.6. Financials (Based on Availability)
  • 11.2.2. Nutricia (Danone)
    • 11.2.2.1. Overview
    • 11.2.2.2. Products & services
    • 11.2.2.3. SWOT Analysis
    • 11.2.2.4. Recent Developments
    • 11.2.2.5. Strategies
    • 11.2.2.6. Financials (Based on Availability)
  • 11.2.3. Abbott
    • 11.2.3.1. Overview
    • 11.2.3.2. Products & services
    • 11.2.3.3. SWOT Analysis
    • 11.2.3.4. Recent Developments
    • 11.2.3.5. Strategies
    • 11.2.3.6. Financials (Based on Availability)
  • 11.2.4. Nestle
    • 11.2.4.1. Overview
    • 11.2.4.2. Products & services
    • 11.2.4.3. SWOT Analysis
    • 11.2.4.4. Recent Developments
    • 11.2.4.5. Strategies
    • 11.2.4.6. Financials (Based on Availability)
  • 11.2.5. B. Braun SE
    • 11.2.5.1. Overview
    • 11.2.5.2. Products & services
    • 11.2.5.3. SWOT Analysis
    • 11.2.5.4. Recent Developments
    • 11.2.5.5. Strategies
    • 11.2.5.6. Financials (Based on Availability)
  • 11.2.6. Medtrition Inc.
    • 11.2.6.1. Overview
    • 11.2.6.2. Products & services
    • 11.2.6.3. SWOT Analysis
    • 11.2.6.4. Recent Developments
    • 11.2.6.5. Strategies
    • 11.2.6.6. Financials (Based on Availability)
  • 11.2.7. Reckitt Benckiser Group PLC
    • 11.2.7.1. Overview
    • 11.2.7.2. Products & services
    • 11.2.7.3. SWOT Analysis
    • 11.2.7.4. Recent Developments
    • 11.2.7.5. Strategies
    • 11.2.7.6. Financials (Based on Availability)
  • 11.2.8. Baxter
    • 11.2.8.1. Overview
    • 11.2.8.2. Products & services
    • 11.2.8.3. SWOT Analysis
    • 11.2.8.4. Recent Developments
    • 11.2.8.5. Strategies
    • 11.2.8.6. Financials (Based on Availability)
  • 11.2.9. Fresenius Kabi AG(Fresenius SE & Co. KGaA)
    • 11.2.9.1. Overview
    • 11.2.9.2. Products & services
    • 11.2.9.3. SWOT Analysis
    • 11.2.9.4. Recent Developments
    • 11.2.9.5. Strategies
    • 11.2.9.6. Financials (Based on Availability)
  • 11.2.10. Other prominent players